Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NRG Oncology
NRG Oncology
University of Pavia
Instituto Oncoclinicas
University of California, Irvine
Chiayi Christian Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University of Pavia
German University in Cairo
University of Pennsylvania
West China Hospital
Stony Brook University
University of Barcelona
Fundacion Clinica Valle del Lili
Taipei Medical University
University Hospital Schleswig-Holstein
Medical College of Wisconsin
First Affiliated Hospital of Guangxi Medical University
Sun Yat-sen University
Institut de cancérologie Strasbourg Europe
Ottawa Hospital Research Institute
West China Hospital
Northwell Health
Sun Yat-sen University
Kaohsiung Medical University Chung-Ho Memorial Hospital
University of Santiago de Compostela
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Chinese University of Hong Kong
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
University of Louisville
University Hospital, Basel, Switzerland
Chang Gung Memorial Hospital
Cyprus University of Technology
Prince of Songkla University
Chang Gung Memorial Hospital
University of California, San Francisco
Taipei Medical University
NYU Langone Health
University of Iowa
University of Miami
National University Hospital, Singapore
Institut Cancerologie de l'Ouest
Second Affiliated Hospital of Nanchang University
Istituto Oncologico Veneto IRCCS
Zhejiang Cancer Hospital
Sun Yat-sen University
Taichung Veterans General Hospital
UConn Health
Sun Yat-sen University
Centre Leon Berard
M.D. Anderson Cancer Center